MME and acute lymphoblastic leukemia: B-ALL originates from immature B-cell precursors and is characterized by the expression of markers such as CD19, CD10 (common acute lymphoblastic leukemia antigen), and terminal deoxynucleotidyl transferase (TdT), reflecting the immaturity of the precursor cells.